Gerber »

Theravance Biopharma shares owned by Gerber

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Gerber from 13F filings

Historical chart of Gerber investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Gerber consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Gerber

Quarter filed Position value Share count Share price at filing
2024-12-31 $94k 10k 9.41
2024-09-30 $81k 10k 8.06
2024-06-30 $85k 10k 8.48
2024-03-31 $90k 10k 8.97
2023-12-31 $112k 10k 11.24

More positions owned by Gerber

Etf Ser Solutions Aptus Defined (DRSK)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Fidelity Covington Trust Enhanced Intl (FENI)
Ark Etf Tr Innovation Etf (ARKK)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Aon Shs Cl A (AON)
NVIDIA Corporation (NVDA)
Amplify Etf Tr Blockchain Ldr (BLOK)
Apple (AAPL)
Ark Etf Tr Fintech Innova (ARKF)
Etf Ser Solutions Aptus Collrd Inv (ACIO)
Vanguard Index Fds Total Stk Mkt (VTI)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Microsoft Corporation (MSFT)
Coinbase Global Com Cl A (COIN)

View all positions for Gerber

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
D. E. Shaw & Co
Oasis Management
Acadian Asset Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
UBS Group

View all funds holding Theravance Biopharma